Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Atrial fibrillation

Not yet recruiting

Registered drug

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Apixaban

Contact Research Centre

Embolism

Not yet recruiting

Investigational

A study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Regn7508

Contact Research Centre

Atrial fibrillation

Not yet recruiting

Investigational

Stroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Regn7508

Contact Research Centre

Embolism venous

Not yet recruiting

Investigational

Safety, Tolerability and Effect of RBD4059 Injection in Adults with Prior VTE After Anticoagulant Therapy and Cancer Patients at High Risk of VTE

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Rbd4059

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

Testing Drug Combinations with GSK4381562A, GSK6097608, GSK4428859 and Dostarlimab in Patients with PD-L1 Positive Head and Neck Cancer That Has Spread or Returned

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Dostarlimab

Contact Research Centre

Cardiac failure

Not recruiting

Investigational

A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Ziltivekimab

Contact Research Centre

Familial hypertriglyceridaemia+1

Not recruiting

Investigational

Study of ISIS 678354 for Patients with Severe High Triglycerides

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Isis 678354 Sodium Salt

Contact Research Centre

Dyslipidaemia

Not recruiting

Registered drug

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Evolocumab

Contact Research Centre

Arteriosclerosis

Not recruiting

Registered drug

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Atorvastatin

Contact Research Centre

Acute coronary syndrome

Not recruiting

Registered drug

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Atrial fibrillation

Not recruiting

Registered drug

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Andexanet Alfa

Contact Research Centre

Arteriosclerosis

Not recruiting

Registered drug

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Inclisiran

Contact Research Centre

Find therapies in clinical trials near you – page 2

32 trials match your criteria

Atrial fibrillation

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Embolism

A study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.

Atrial fibrillation

Stroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)

Embolism venous

Safety, Tolerability and Effect of RBD4059 Injection in Adults with Prior VTE After Anticoagulant Therapy and Cancer Patients at High Risk of VTE

Squamous cell carcinoma of head and neck

Testing Drug Combinations with GSK4381562A, GSK6097608, GSK4428859 and Dostarlimab in Patients with PD-L1 Positive Head and Neck Cancer That Has Spread or Returned

Cardiac failure

A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

Familial hypertriglyceridaemia+1

Study of ISIS 678354 for Patients with Severe High Triglycerides

Dyslipidaemia

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Arteriosclerosis

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Acute coronary syndrome

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Atrial fibrillation

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Arteriosclerosis

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.